Patients In US Struggle To Obtain Monkeypox Drug Due To Limited Access

The New York Times (8/6, Mandavilli) reported, “The only drug available to treat monkeypox is so difficult to access that just a fraction of the nearly 7,000 patients in the United States have been given it.” Health officials “designated tecovirimat, also...